Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Entero Therapeutics Inc
ENTO
Healthcare
Biotechnology
Entero Therapeutics, Inc., formerly First Wave BioPharma, Inc., is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. Its programs address unmet needs in GI health and include latiglutenase, a Phase III-ready, oral biotherapeutic designed to aid gluten digestion and potentially reduce symptoms of...
celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for multiple GI conditions, including gastroparesis, and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency. The Company also intends to develop Niclosamide, an oral small molecule anti-inflammatory inhibitor therapy for the treatment of ulcerative proctitis and ulcerative proctosigmoiditis, and immune checkpoint inhibitor-associated colitis and diarrhea in metastatic cancer patients.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ENTO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jan 13, 2023 10:20am
New Press Release - First Wave BioPharma Announces Results of Special Meeting of Stockholders
BOCA RATON, Fla., Jan. 13, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jan 09, 2023 9:10am
New Press Release - First Wave BioPharma Announces Adjournment of Special Meeting
BOCA RATON, Fla., Jan. 09, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jan 05, 2023 9:46am
New Press Release - ZyVersa Therapeutics Appoints Three New Board Members
New appointments bring expertise and proven leadership to ZyVersa to support advancement and development of VAR 200 for renal disease, and IC 100 for inflammatory diseasesWESTON, Fla., Jan. 5, 2023 /PRNewswire/ -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or "ZyVersa"), a clinical- stage...
read article.
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 03, 2023 10:39am
FWBI ....has to hold ~ $0.73 or next support is...
Sub $0.65
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 03, 2023 8:57am
FWBI..... Back to "The Woodshed" for u !
LoL
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 29, 2022 4:19pm
FWBI..... Well.... I thought I was smart ; )
98 cents high in AH trading...... Sheesh On to the next deal.... Cheers !
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 29, 2022 3:47pm
FWBI ..... Thanks for the Dough Mr. M
Unbelievable Cheers !!!
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Dec 29, 2022 1:33pm
RE:FWBI .... Mr M is filling "The Chasers".... Lol
Wortha repeat ? LoL
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 27, 2022 3:07pm
FWBI ...back to the wood shed for another a$$ whoopin ; )
Way to go Maggot
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 27, 2022 12:47pm
FWBI ....all show and no dough
Big bid lasted all but 3 mins ; )
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 27, 2022 12:42pm
FWBI..... Is this your claim to fame ?
First Wave BioPharma to Participate in BIO Partnering @ JPM During ¢ € J.P. Morgan Week 2023 ¢ € 2022-12-12 04:30 ET - News Release BOCA RATON, Fla., Dec. 12,
...more
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 27, 2022 12:40pm
FWBI ....exactly what I thought
Sheesh...... go sh8 in a river
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 27, 2022 12:37pm
FWBI ..... all smoke and mirrors eh ?
U have zero power !!!!
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 27, 2022 12:33pm
FWBI .... Mr. Maggot....10 : 1 ur Mother doesn't even
like you .... LoL
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 27, 2022 12:32pm
FWBI .... The Front Loader is listening ; )
Mr. M is that u bid whacking and flishing out the chasers ???? Geez you must be a real penny pincher ; )
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Learn How this Company is Disrupting Point-of-Care Testing
Why Dozens of Pro Athletes are Paying Attention to this Product
Do you want to stay ahead of the markets? See how DealRoom can help.